NASDAQ:HOLX
Hologic is no longer public. The company wrapped up its sale to Blackstone and TPG, with the women’s health and diagnostics firm now in private-equity hands—José Almeida, previously at Baxter, will take the helm.…
Company hubNASDAQ:HOLX
Follow the latest HOLX (HOLX) company news, earnings coverage and investor analysis from TechStock².
All coverage
Hologic has locked in all the necessary regulatory sign-offs for its sale to Blackstone and TPG, with the $18.3 billion take-private transaction on track…
Hologic announced Monday that Chief Executive Steve MacMillan plans to step down once the women’s health med-tech firm’s sale to Blackstone and TPG wraps…
Dec. 24, 2025 — Hologic, Inc. finished the shortened Christmas Eve session at $74.50, with the stock trading around $74.80 in after-hours activity as…
Blackstone’s latest results painted a mixed picture. The firm reported distributable earnings of $1.889 billion, up 48% from a year ago and well above…
Hologic is a Marlborough, MA–based medical technology firm focused on women’s health. Its products include mammography and breast biopsy systems, cervical cancer tests, surgical…
